GlassScriptPhysician profile
David W Mcclure
NPI 1275538878
$3,443.51
in general payments reported to CMS, 2019-2025
41 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $271 · 2021: $472 · 2022: $500 · 2023: $586 · 2024: $678 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $928.38 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $332.69 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $209.55 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Abbvie INC. | $204.19 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $199.83 | 2019-2022 | |
| Glaxosmithkline, LLC. | $191.20 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Dexcom, INC. | $105.11 | 2023-2025 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $95.64 | 2023-2024 | Gemtesa |
| Abbott Laboratories | $94.19 | 2021-2023 | Freestyle Libre 3 |
| Pfizer INC. | $85.70 | 2019-2025 | |
| Exact Sciences Corporation | $80.70 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.56 | 2021-2025 | Jardiance, Synjardy |
| Amarin Pharma, INC. | $69.49 | 2019-2021 | |
| Eisai INC. | $52.10 | 2021-2023 | |
| Otsuka America Pharmaceutical, INC. | $50.48 | 2021-2025 | Rexulti |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mcclure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.